AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11566519 — intervention group
Group type: COMPARATOR
Intervention: No LEC removal (Group A)
Number of subjects: 60
Study 9631312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine bismuth citrate (RBC) 400 mg bid for 4 weeks plus amoxicillin 500 mg qid for 2 weeks
Number of subjects: 229
Study 9631312 — intervention group
Group type: COMPARATOR
Intervention: RBC 400 mg bid for 4 weeks and placebo qid for 2 weeks
Number of subjects: 229
Study 9631312 — intervention group
Group type: COMPARATOR
Intervention: Placebo bid for 4 weeks and amoxicillin 500 mg qid for 2 weeks
Number of subjects: 229
Study 9631312 — intervention group
Group type: COMPARATOR
Intervention: Placebo bid for 4 weeks and placebo qid for 2 weeks
Number of subjects: 229
Study 7524591 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl
Number of subjects: 195
Study 7524591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 195
Study 30276799 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced support methods (phone calls, text messages, Facebook, email) to encourage medical check-ups
Number of subjects: 53
Study 30276799 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 53
Study 28673304 — intervention group
Group type: EXPERIMENTAL
Intervention: French version of the query builder
Number of subjects: 42
Study 28673304 — intervention group
Group type: COMPARATOR
Intervention: English version of the query builder
Number of subjects: 42
Study 25647644 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training (3 times per week for 10 weeks)
Number of subjects: 27
Study 25647644 — intervention group
Group type: COMPARATOR
Intervention: Normal training (control group)
Number of subjects: 27
Study 23456018 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific templates
Number of subjects: 34
Study 23456018 — intervention group
Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 34
Study 20808072 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity exercise (LI): 40% V'O(2)max
Number of subjects: 20
Study 20808072 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise (HI): 70% V'O(2)max
Number of subjects: 20
Study 18609044 — intervention group
Group type: EXPERIMENTAL
Intervention: No touch (NT) technique
Number of subjects: 93
Study 18609044 — intervention group
Group type: COMPARATOR
Intervention: Conventional (C) technique
Number of subjects: 93
Study 16624847 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (TCC; n = 11)
Number of subjects: 19
Study 16624847 — intervention group
Group type: COMPARATOR
Intervention: Brisk Walking Group (BWG; n = 8)
Number of subjects: 19
Study 14707892 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted insulin dose adjustment
Number of subjects: 10
Study 14707892 — intervention group
Group type: COMPARATOR
Intervention: No computer assistance
Number of subjects: 10
Study 10513041 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg PYR
Number of subjects: 20
Study 10513041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 8558158 — intervention group
Group type: COMPARATOR
Intervention: FVEP P2 latency
Number of subjects: 52
Study 8558158 — intervention group
Group type: EXPERIMENTAL
Intervention: Discriminant function using two ERP and two FVEP component measures
Number of subjects: 52
Study 8558158 — intervention group
Group type: EXPERIMENTAL
Intervention: FVEP latencies
Number of subjects: 52
Study 8558158 — intervention group
Group type: EXPERIMENTAL
Intervention: P300 component latency
Number of subjects: 52
Study 8558158 — intervention group
Group type: COMPARATOR
Intervention: ERP component (N2/P300) amplitudes or latencies
Number of subjects: 52
Study 2050326 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐adenosyl‐L‐methionine, 900 mg, administered via daily intravenous infusions for 20 days
Number of subjects: 18
Study 2050326 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered via daily intravenous infusions for 20 days
Number of subjects: 18
Study 6402356 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication (phenobarbitone) during pregnancy
Number of subjects: 70
Study 6402356 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication (multiple agents) during pregnancy
Number of subjects: 70
Study 6402356 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticonvulsant medication during pregnancy
Number of subjects: 70
Study 6402356 — intervention group
Group type: EXPERIMENTAL
Intervention: Epileptic parents
Number of subjects: 70
Study 30523758 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 100 mg/m2 plus gemcitabine 1,000 mg/m2 (arm B)
Number of subjects: 221
Study 30523758 — intervention group
Group type: EXPERIMENTAL
Intervention: NAB-paclitaxel 125 mg/m2 plus gemcitabine 1,000 mg/m2 (arm D)
Number of subjects: 221
Study 30661560 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention condition (universal prevention program)
Number of subjects: 695
Study 30661560 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 695
Study 28092306 — intervention group
Group type: EXPERIMENTAL
Intervention: K(D)PT (pooled group)
Number of subjects: 0
Study 28092306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25901642 — intervention group
Group type: EXPERIMENTAL
Intervention: Keratin gel
Number of subjects: 20
Study 25901642 — intervention group
Group type: COMPARATOR
Intervention: Aqueous cream (Control)
Number of subjects: 20
Study 24364085 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan
Number of subjects: 200
Study 24364085 — intervention group
Group type: COMPARATOR
Intervention: Placebo (500 mL saline solution)
Number of subjects: 200
Study 22026530 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-forgiveness intervention (4-hour duration)
Number of subjects: 79
Study 22026530 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 79
Study 19279301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet
Number of subjects: 63
Study 19279301 — intervention group
Group type: COMPARATOR
Intervention: Higher-glycemic index diet (control)
Number of subjects: 63
Study 19279301 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet (post-switch)
Number of subjects: 63
Study 19279301 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstetric and fetal outcomes
Number of subjects: 63
Study 16881463 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight-bearing MWM treatment technique
Number of subjects: 16
Study 16881463 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-weight-bearing MWM treatment technique
Number of subjects: 16
Study 16881463 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 16
Study 15747758 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-incision, minimal dissection procedure
Number of subjects: 72
Study 15747758 — intervention group
Group type: COMPARATOR
Intervention: Traditional aponeurotic approach
Number of subjects: 72
Study 11170060 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha 2B therapy
Number of subjects: 121
Study 9753190 — intervention group
Group type: EXPERIMENTAL
Intervention: No-go trials (red square presented, subjects instructed not to respond)
Number of subjects: 5
Study 9753190 — intervention group
Group type: COMPARATOR
Intervention: Go trials (green square presented, subjects responded by pushing a button)
Number of subjects: 5
Study 7836111 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate (HCHO) diet
Number of subjects: 9
Study 7836111 — intervention group
Group type: COMPARATOR
Intervention: High-fat (HFAT) diet
Number of subjects: 9
Study 2458094 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride (intravenous administration)
Number of subjects: 0
Study 2458094 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 2458094 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride with beta-blocker or serotonin antagonist pretreatment
Number of subjects: 0
Study 2458094 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride
Number of subjects: 0
Study 29391008 — intervention group
Group type: EXPERIMENTAL
Intervention: Home fortification with iron-containing micronutrient powders (two different formulations)
Number of subjects: 338
Study 29391008 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reporting
Number of subjects: 338
Study 29391008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sachet count
Number of subjects: 338
Study 29391008 — intervention group
Group type: EXPERIMENTAL
Intervention: Home fortification with iron-containing micronutrient powders
Number of subjects: 338
Study 27428280 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerial rope bridge task (stress group)
Number of subjects: 68
Study 27428280 — intervention group
Group type: COMPARATOR
Intervention: Cushion on the ground (control condition)
Number of subjects: 68
Study 25913828 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-15
Number of subjects: 60
Study 25913828 — intervention group
Group type: COMPARATOR
Intervention: PCV-7
Number of subjects: 60
Study 25913828 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-15 and PCV-7
Number of subjects: 60
Study 23275352 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide treatment for 12 weeks
Number of subjects: 0
Study 23275352 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects and subjects with PCOS
Number of subjects: 0
Study 23275352 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 21986347 — intervention group
Group type: EXPERIMENTAL
Intervention: 24‐minute video behavior support intervention with a workbook and 5 sessions of telephone coaching by a trained diabetes nurse
Number of subjects: 201
Study 21986347 — intervention group
Group type: COMPARATOR
Intervention: 20‐page brochure developed by the National Diabetes Education Program
Number of subjects: 201
Study 17681544 — intervention group
Group type: EXPERIMENTAL
Intervention: BRT (capnometry‐assisted breathing therapy)
Number of subjects: 37
Study 17681544 — intervention group
Group type: COMPARATOR
Intervention: Delayed‐treatment control group
Number of subjects: 37
Study 16504907 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands off technique
Number of subjects: 70
Study 16504907 — intervention group
Group type: COMPARATOR
Intervention: Hands on technique
Number of subjects: 70
Study 12602447 — intervention group
Group type: EXPERIMENTAL
Intervention: Temazepam (30 mg) administered before daytime sleep
Number of subjects: 16
Study 12602447 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose-filled capsule)
Number of subjects: 16
Study 10981531 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled budesonide, 500 microg three times per day for 7 days (Group II)
Number of subjects: 117
Study 10981531 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized budesonide, 500 microg twice per day for two months (Group III)
Number of subjects: 117
Study 10981531 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic treatment only (Group I)
Number of subjects: 117
Study 8915143 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol 0.005% ointment
Number of subjects: 0
Study 8915143 — intervention group
Group type: COMPARATOR
Intervention: Sodium lauryl sulphate (SLS) 1% aqueous solution
Number of subjects: 0
Study 8915143 — intervention group
Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study 1529737 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 149
Study 1529737 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 7320203 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 12
Study 7320203 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral self-control training
Number of subjects: 12
Study 7320203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7320203 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 12
Study 30688550 — intervention group
Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 36
Study 30688550 — intervention group
Group type: COMPARATOR
Intervention: Control (lifestyle changes only)
Number of subjects: 36
Study 28191264 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Relapse Prevention (MBRP)
Number of subjects: 63
Study 28191264 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 63
Study 26048637 — intervention group
Group type: EXPERIMENTAL
Intervention: Kudzu extract (Alkontrol‐Herbal™) 2g total with an active isoflavone content of 520mg
Number of subjects: 20
Study 26048637 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 26048637 — intervention group
Group type: EXPERIMENTAL
Intervention: Kudzu extract (Alkontrol‐Herbal™)
Number of subjects: 20
Study 24028826 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based self-management (IBSM) support
Number of subjects: 200
Study 24028826 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 200
Study 21899646 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) session
Number of subjects: 20
Study 18675974 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist
Number of subjects: 10
Study 18675974 — intervention group
Group type: COMPARATOR
Intervention: Earlier failed IVF attempts
Number of subjects: 10
Study 17875180 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 9193
Study 17875180 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 9193
Study 16736099 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid protein substitute
Number of subjects: 27
Study 14572122 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light exposure (1,000 lux)
Number of subjects: 16
Study 14572122 — intervention group
Group type: COMPARATOR
Intervention: Dim light exposure (< 5 lux)
Number of subjects: 16
Study 11957318 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyester clothing with low moisture absorption and high air permeability (B clothing)
Number of subjects: 0
Study 11957318 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotton clothing with high moisture absorption and high air permeability (C clothing)
Number of subjects: 0
Study 11957318 — intervention group
Group type: EXPERIMENTAL
Intervention: All three kinds of clothing (A, B, C)
Number of subjects: 0
Study 7755827 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine-epinephrine (TLE)
Number of subjects: 35
Study 7755827 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine-adrenaline-cocaine (TAC)
Number of subjects: 35
Study 7755827 — intervention group
Group type: COMPARATOR
Intervention: TAC
Number of subjects: 35
Study 7755827 — intervention group
Group type: EXPERIMENTAL
Intervention: TLE
Number of subjects: 35
Study 2270298 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalline penicillin (i.v. infusions for 10 days, daily dose of 20-24 mega U., combined with probenecid, followed by i.m. procaine penicillin in daily dose of 1.2 mega U., total dose 12-50 mega U.)
Number of subjects: 57
Study 2270298 — intervention group
Group type: COMPARATOR
Intervention: Procaine penicillin (i.m. in daily dose of 1.2 mega U., total dose 24-60 mega U.)
Number of subjects: 57
Study 7015539 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol
Number of subjects: 0
Study 7015539 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 0
Study 31002442 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioural therapy pain management programme (CBT-PMP), six modules delivered once weekly.
Number of subjects: 69
Study 31002442 — intervention group
Group type: COMPARATOR
Intervention: Control group (details not specified).
Number of subjects: 69
Study 28339433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 42
Study 28339433 — intervention group
Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 42
Study 28339433 — intervention group
Group type: COMPARATOR
Intervention: Methadone plus Ketamine
Number of subjects: 42
Study 26656463 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate alcohol consumption (2-3 units/day)
Number of subjects: 321
Study 26656463 — intervention group
Group type: COMPARATOR
Intervention: 1 or <1 unit/day
Number of subjects: 321
Study 26656463 — intervention group
Group type: COMPARATOR
Intervention: Abstinent patients
Number of subjects: 321
Study 26656463 — intervention group
Group type: COMPARATOR
Intervention: More than 3 units/day
Number of subjects: 321
Study 22719022 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor for 12 months
Number of subjects: 0
Study 22719022 — intervention group
Group type: COMPARATOR
Intervention: Generic clopidogrel
Number of subjects: 0
Study 21694608 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz with stavudine + lamivudine
Number of subjects: 68
Study 21694608 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 68
Study 21694608 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir
Number of subjects: 68
Study 18296968 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-minute rest interval group
Number of subjects: 15
Study 18296968 — intervention group
Group type: COMPARATOR
Intervention: 4-minute rest interval group
Number of subjects: 15
Study 16401539 — intervention group
Group type: EXPERIMENTAL
Intervention: U-clips
Number of subjects: 30
Study 16401539 — intervention group
Group type: COMPARATOR
Intervention: Suture
Number of subjects: 30
Study 12741429 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol 2 mg
Number of subjects: 12
Study 12741429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15635800 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of 96% ethanol into the cyst after evaluation under ultrasonographic control
Number of subjects: 0
Study 15635800 — intervention group
Group type: COMPARATOR
Intervention: Simple evaluation of the contents of the cyst
Number of subjects: 0
Study 8775105 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1-3 vol.% (group 1, n = 25)
Number of subjects: 50
Study 8775105 — intervention group
Group type: COMPARATOR
Intervention: Propofol (group 2, n = 25)
Number of subjects: 50
Study 1631216 — intervention group
Group type: EXPERIMENTAL
Intervention: Textured implants
Number of subjects: 25
Study 1631216 — intervention group
Group type: COMPARATOR
Intervention: Smooth implants
Number of subjects: 25
Study 6228019 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (n = 17)
Number of subjects: 54
Study 6228019 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS (low-intensity transcutaneous nerve stimulation, n = 18)
Number of subjects: 54
Study 6228019 — intervention group
Group type: COMPARATOR
Intervention: TENS-dead battery (placebo, n = 18)
Number of subjects: 54
Study 31005828 — intervention group
Group type: EXPERIMENTAL
Intervention: Social workers managing LACCL expectations and building relationships by rationing care according to role constraints and sometimes going 'above and beyond' statutory care.
Number of subjects: 44
Study 31005828 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal carers conceptualizing care in terms of dedication and discipline.
Number of subjects: 44
Study 31005828 — intervention group
Group type: EXPERIMENTAL
Intervention: LACCL's desire for care that felt familial and went beyond minimum standards.
Number of subjects: 44
Study 30451774 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone assistance nursing program (3 days per week coaching sessions)
Number of subjects: 70
Study 30451774 — intervention group
Group type: COMPARATOR
Intervention: Conventional postoperative management (control group)
Number of subjects: 70
Study 26955640 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Vita Personal Health Record with Self-Management Support and Coaching
Number of subjects: 132
Study 24631638 — intervention group
Group type: EXPERIMENTAL
Intervention: PGX(®) 2.5g
Number of subjects: 10
Study 24631638 — intervention group
Group type: EXPERIMENTAL
Intervention: PGX(®) 7.5g
Number of subjects: 10
Study 24631638 — intervention group
Group type: EXPERIMENTAL
Intervention: PGX(®) (7.5g)
Number of subjects: 10
Study 24631638 — intervention group
Group type: COMPARATOR
Intervention: Inulin 5g
Number of subjects: 10
Study 22143432 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-alanine (BA)
Number of subjects: 18
Study 20300914 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally modified navigator model including both face‐to‐face and telephone formats
Number of subjects: 0
Study 18157310 — intervention group
Group type: EXPERIMENTAL
Intervention: Spherical orbital implant
Number of subjects: 21
Study 18157310 — intervention group
Group type: EXPERIMENTAL
Intervention: Quad-motility orbital implant
Number of subjects: 21
Study 18157310 — intervention group
Group type: COMPARATOR
Intervention: Both spherical and quad-motility orbital implants
Number of subjects: 21
Study 15329588 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.15 microg x kg(‐1) x min(‐1)
Number of subjects: 40
Study 15329588 — intervention group
Group type: COMPARATOR
Intervention: Morphine 0.75 microg x kg(‐1) x min(‐1)
Number of subjects: 40
Study 11345288 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) nasal spray, 200 microg daily for 2 weeks
Number of subjects: 42
Study 9202835 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 1200 mg/day for 6 months
Number of subjects: 47
Study 9202835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 7526102 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of GSNO starting 10 min before PTCA
Number of subjects: 13
Study 7526102 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 patients receiving standard treatment with aspirin, glyceryl trinitrate, and heparin)
Number of subjects: 13
Study 3299004 — intervention group
Group type: EXPERIMENTAL
Intervention: Org OD 14 2.5 mg/day
Number of subjects: 98
Study 3299004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 28917688 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth assessment
Number of subjects: 253